Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
Carlson AL, Mullen DM and Bergenstal RM
Diabetes Technology & Therapeutics. 2017:19(S2):S4-11.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Flash Glucose Monitoring: The Future Is Here
Garg SK, Akturk HK
Diabetes Technology & Therapeutics. 2017:19(S2):S1-3
Leggi
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Kosiborod M, Cavender MA, Fu aZ, et al.
Circulation. Pub. online May 18, 2017
Leggi
Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration
Fernandez-Mendoza J, He F, LaGrotte C,et al.
J Am Heart Assoc. Pub. online May 17, 2017
Leggi
Early Invasive Strategy and In-Hospital Survival Among Diabetics with Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight
Mahmoud AN, Elgendy IY, Mansoor H,et al.
J Am Heart Assoc. 2017;6:e005369
Leggi
Merits of Invasive Strategy in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome
Jneid H
J Am Heart Assoc. Pub. online May 20, 2017
Leggi
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis
Baker WL, Buckley LF, Kelly MS, et al.
J Am Heart Assoc. Pub. online May 18, 2017
Leggi
EMPA-REG OUTCOME: The Nephrologist’s Point of View
Wanner C
Am J Med. Pub. online May 16, 2017
Leggi
New Hope for People with Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone (Editorial)
Rydén L, Linda Mellbin L
Circulation 2017;135:1894-
Leggi
Evidence for Two Distinct Phenotypes of Chronic Kidney Disease in Individuals with Type 1 Diabetes Mellitus
Penno G, Russo E, Garofolo M, et al.
Diabetologia 2017;60(6):1102-13
Leggi